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The pre-B cell receptor (pre-BCR) plays a crucial role
in the development of immatureBcells. Althoughcer-
tain aspects of proximal pre-BCR signaling have
been studied, the intermediate signal transducers
and the distal transcription modulators are poorly
characterized. Here, we demonstrate that deletion
of both Erk1 and Erk2 kinases was associated with
defective pre-BCR-mediated cell expansion as well
as a block in the transition of pro-B to pre-B cells.
Phosphorylation of transcription factors Elk1 and
CREBwasmediatedbyErk, and adominant-negative
mutation in the Erk-mediated phosphorylation sites
of Elk1 or CREB suppressed pre-BCR-mediated cell
expansion as well as expression of genes including
Myc, which is involved in the cell-cycle progression.
Together, our results identify a crucial role for Erk ki-
nases in regulating B cell development by initiating
transcriptional regulatory network and thereby pre-
BCR-mediated cell expansion.
INTRODUCTION
B cell maturation can be divided into a series of developmental
stages that arecharacterizedby thedifferential expressionof a va-
riety of marker proteins and changes in the rearrangement status
of the immunoglobulinheavy (Igh) and light (Igl) chaingenes (Hardy
and Hayakawa, 2001). Igh gene rearrangement is initiated during
pro-B cell stage, and the resulting product in association with l5
and VpreB forms a surface-expressed pre-B cell receptor (pre-
BCR). Correct assembly of the pre-BCR triggers a signaling cas-
cade that induces proliferation, downregulation of the pre-BCR
complex, and differentiation into small pre-B cells. Subsequently,
productive gene rearrangement at the Igl loci takes place, leading
tosynthesis of IgMon the surfaceof immatureBcells (Meffre et al.,
2000). Other pathways have been shown to participate in check-
pointsduringBcell development. Interleukin (IL)-7, a cytokinepro-duced by stromal cells, was identified as a proliferation factor for
the B cell lineage. Indeed, disruption of the IL-7 signaling pathway
prevents the appearance of the pre-BCR-expressing population
in the bone marrow (Hendriks and Middendorp, 2004).
Mice that are deficient in genes encoding components of the
proximal pre-BCR signaling cascade have provided valuable in-
sights into the nature of the pre-BCR signal. Signaling from the
pre-BCR depends critically on the receptor-associated trans-
membranemolecules Iga and Igb, in particular on their immunor-
eceptor tyrosine-based activationmotifs (ITAMs) in the cytoplas-
mic domains (Meffre et al., 2000; Hendriks and Middendorp,
2004). After tyrosine phosphorylation of the Iga and Igb ITAMs,
the protein tyrosine kinase (PTK) Syk is recruited and subse-
quently activated. The binding of Syk to the phosphorylated
Iga and Igb also places the active Syk in the right position to allow
further phosphorylation of neighboring ITAM sequences. This
results in further Syk recruitment and activation (Jumaa et al.,
2005). Then, activated Syk phosphorylates phospholipase C
(PLC)-g2, leading to the generation of the second messengers
diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (Kurosaki,
2002). The essential role of such an ITAM-Syk signaling circuit in
B cell development has been underscored by impaired pre-B cell
development in mice carrying a mutated Iga ITAM with a trunca-
tion of Igb (IgaDC IgbDC, IgaFF IgbDC) or inmice deficient in Syk,
alone or together with Zap70 (Reichlin et al., 2001; Kraus et al.,
2001; Turner et al., 1995; Schweighoffer et al., 2003). Another
model has also emerged that proposes that the Syk-indepen-
dent, but Src family PTKs (SFKs)-dependent, NF-kB signaling
pathway participates in pre-B cell development. In fact, in Blk
Fyn Lyn triple Src-PTK-deficient mice, B cell development is
arrested prior to the pre-B cell stage (Saijo et al., 2003).
Although much has been learned as to the functions of the Iga
and Igb ITAMs, Src-family PTKs, and Syk-family PTKs, less is
known about the potential connection between such PTKs and
nuclear events that govern pre-BCR-mediated cell expansion
and differentiation. In this regard, serine and threonine kinases
downstream of the Syk-family and Src-family PTKs could be
an attractive candidate because some of serine and threonine
kinases are known to shuttle between the cytoplasm and the nu-
cleus and/or to regulate transcription factors, thereby controllingImmunity 28, 499–508, April 2008 ª2008 Elsevier Inc. 499
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in transformed B cells (Jiang et al., 1998), we hypothesized that
Erk might interface Syk with nuclear events, thereby contributing
to the pre-BCR-mediated responses.
To test this hypothesis, we have generated mice deficient in
both Erk1 and Erk2. By using these mice, we show an essential
role of Erk1 and Erk2 in the pre-BCR-mediated cell expansion as
well as in the transition of pro- to pre-B cells. Erk1 and Erk2 ac-
tivation is dependent on expression of Syk and Zap70. Activated
Erk1 and Erk2 contribute to the phosphorylation of transcription
factors such as Elk1 and CREB and their activation, which in turn
regulate genes involved in cell expansion. Together, our study
identifies Erk1 and Erk2 as key participants in the pre-BCR check
point and suggests the potential mechanism by which Erk1 and
Erk2 exert their function.
RESULTS
Erk1 and Erk2 Are Indispensable for a Transition
of Pro-B to Pre-B Cells
Targeted disruption of Erk2 results in embryonic lethality due to
defective placental development (Hatano et al., 2003). Thus, in
order to examine the effect of the double deficiency of Erk1 and
Erk2 on B cell development and function, we crossedMapk3/
Mapk1fl/fl (encoding Erk1 and Erk2, respectively) mice with
Mx-cre mice that bear the cre transgene under the control of
type I interferon-inducible Mx promoter (referred to hereafter as
inducible-Erk double-deficientmice). Twoweeks after p(I)p(C) in-
jections, these mice showed a reduction in the number of pre-B
cells (B220lowIgMCD43) to 7%of wild-type controls and a cor-
responding decrease in immature B cells (B220lowIgM+CD43) in
the bone marrow (Figures 1A and 1B). In contrast, Erk1-deficient
(Mapk3/ Mapk1fl/fl) or inducible Erk2-deficient (Mx-cre+
Mapk3+/ Mapk1fl/fl) mice did not show such a drastic reduction
of the pre-B or the immature B cell compartment after p(I)p(C) in-
jection (Figures 1A and 1B). Pro-B cells can be further subdivided
on the basis of surface expression of HSA andBP-1 into subfrac-
tions A, B, C, and C0. The BP-1+HSAhigh cells (fraction C0) repre-
sent cycling cells that are in the transition from pro-B to pre-B
and that are in the process of downregulating surface CD43.
We found that the ratio of BP-1+HSAhigh (fraction C0) cells to
BP-1+HSAlow (fraction C) cells in p(I)p(C)-treated inducible-Erk
double-deficient mice was much lower than in other genotypes
(Figure 1A), indicating a defect in the transition from pro-B to
pre-B cells in these mice.
Deletion of theMapk1 genomic locus was assessed by quan-
titative PCR with primers that detect the Mapk1 flox (Mapk1fl)
and null (Mapk1D) alleles. After p(I)p(C) injection, bone-marrow
pro-B cells from inducible-Erk2-deficient or -Erk double-
deficient mice showed efficient deletion in the Mapk1fl allele
of almost 95% (Figure 1C). However, recirculating B cells
(B220highIgM+) in the bone marrow hardly deleted Mapk1
(Figure S1A available online). Two weeks after p(I)p(C) injec-
tions, in the spleen of inducible-Erk double-deficient mice,
90% of the immature B cells (B220+IgMhighIgDlow) were lost
(Figure S1B), and the remaining splenic B cells were also derived
from cells that had escaped Mapk1 deletion (Figure S1A).
Because Erk1 and Erk2 are widely expressed kinases in other
cell types such as bone-marrow stromal cells, we next deter-500 Immunity 28, 499–508, April 2008 ª2008 Elsevier Inc.mined whether the observed defect in B cell development was
due to an intrinsic lack of Erk1 and Erk2. Therefore, we reconsti-
tuted irradiated an alymphoid host deficient in recombination-
activating gene 1 (Rag1) with bone-marrow cells from wild-
type, Erk1-deficient, inducible-Erk2-deficient, or inducible-Erk
double-deficient mice. Two weeks after p(I)p(C) injection, in con-
trast to other genotypes, inducible-Erk double-deficient bone-
marrow cells were unable to reconstitute B cell development
(Figures 2A and 2B). Together, these results show that the
impaired early B cell development in the absence of Erk1 and
Erk2 is cell autonomous.
Figure 1. B Cell Development Is Blocked at the Pro-B Cell Stage in
Inducible-Erk Double-Deficient Mice
(A) Representative FACS analysis of bone marrow from Mx-cre+ Mapk3+/+
Mapk1+/+ (Control), Mapk3/ Mapk1fl/fl (Erk1-deficient), Mx-cre+ Mapk3+/
Mapk1fl/fl (inducible-Erk2-deficient), or Mx-cre+ Mapk3/ Mapk1fl/fl
(inducible-Erk double-deficient) mice at day 14 after the first of three p(I)p(C)
injections to all mice. Numbers represent percentages of cells within the
live cell fraction (B220 versus IgM and B220 versus CD43), B220low B cell
fraction (IgM versus CD25) or B220+CD43+ pro-B cell fraction (BP-1 versus
HSA).
(B) Numbers of B cell subpopulations in bone marrow. Bars and error
bars represent mean and SD of cells in two femurs and tibias per mouse.
Pro-B, B220+IgMCD43+; Pre-B, B220lowIgMCD43; Immature B; and
B220lowIgM+CD43 cells are shown. *p = 0.003, **p = 0.001.
(C) Genomic PCRanalysis for determining the ratio ofMapk1-flox (Mapk1fl) ver-
sus deleted (Mapk1D) alleles in bone-marrow pro-B cells (B220+IgMCD43+).
Cells were prepared by FACS sorting from Erk1-deficient, inducible-Erk2-defi-
cient, or inducible-Erk double-deficient mice at day 14 after the first of three
p(I)p(C) injections. Genomic PCR for the Syk locus was performed as a loading
control.
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Signaling
Because Erk kinases are known to be involved in the regulation
of proliferation in other cell types such as fibroblasts, we exam-
ine the cell-cycle status of pro-B cells from various genotypes.
As shown in Figures 3A and 3B, the proportion of pro-B cells
that entered the S phase was considerably decreased in the
p(I)p(C)-treated inducible-Erk double-deficient mice. Given the
importance of expression of the pre-BCR and IL-7 receptor
(IL7R) in cell-cycle progression of pro- and pre-B cells (Meffre
et al., 2000; Hendriks and Middendorp, 2004), we reasoned
that the above observation could be due to impaired expression
of these receptors or defective signaling through the receptors.
The former possibility is unlikely because cell-surface expres-
sion of both IL7Ra and pre-BCR was not impaired in p(I)p(C)-
treated inducible-Erk double-deficient pro-B cells (Figures 3C
and 3D). Before addressing the latter possibility, we tested
whether Erk kinases are indeed activated after pre-BCR expres-
sion or IL-7 stimulation. Introduction of exogenous mH into
Rag1/ pro-B cells resulted in the formation of surface pre-
Figure 2. Impaired B Cell Development in Inducible-Erk Double-
Deficient Mice Is B Cell Intrinsic
(A) Sublethally irradiated recipient mice (Rag1/, Ly9.1+) were reconstituted
with bone marrow from Mx-cre+ Mapk3+/+ Mapk1+/+ (Control), Mapk3/
Mapk1fl/fl (Erk1-deficient), Mx-cre+ Mapk3+/ Mapk1fl/fl (inducible-Erk2-defi-
cient), or Mx-cre+ Mapk3/ Mapk1fl/fl (inducible-Erk double-deficient) mice.
Recipient mice were analyzed at day 14 after the first of three p(I)p(C) injec-
tions. Representative FACS analyses of the B cell population of donor origin
cells (Ly9.1) in the bone marrow are shown. Numbers indicate the percent-
ages of gated populations as described in the Figure 1 legend. All recipient
mice (n = 4) showed similar phenotypes.
(B) Genomic PCR analysis to confirm the deletion ofMapk1 flox allele in donor
origin pro-B cells (Ly9.1-B220+IgM-CD43+). Cells were prepared by FACS
sorting from Erk1-deficient, inducible-Erk2-deficient, or inducible-Erk double-
deficient reconstituted mice at day 14 after the first of three p(I)p(C) injections.BCR, and an increased phosphorylation level of the Erk kinases,
demonstrating the connection between pre-BCR expression
and Erk kinase activation (Figure 4A). Moreover, only marginal
activation of the Erk kinases was observed in pro-B cells after
IL-7 stimulation alone (data not shown).
To address the effects of Erk1 and Erk2 ablation on pre-BCR-
mediated cell expansion, we compared the proliferation capacity
of pro-B cells among various genotypes. As previously demon-
strated (Fleming and Paige, 2001), compared with wild-type
pro-B cells, inability of expression of pre-BCR complex on the
surface of pro-B cells such as mMT or Rag1/ resulted in a se-
vere reduction in their proliferation at low concentration of IL-7
(Figure 4B). Such a defect in Rag1/ pro-B cells could be re-
stored by the enforced expression of mH to a level equal to that
of wild-type cells, thereby establishing the requirement of pre-
BCR for normal proliferation. Importantly, this proliferation was
abrogated in pro-B cells deficient in both Erk1 and Erk2, but
not in either Erk1 or Erk2 alone, and the proliferation was similar
to that of mMT or Rag1/ pro-B cells (Figure 4B). These results
suggest that Erk kinases participate in pre-BCR-mediated cell
expansion.
Figure 3. Mutation of Erk1 and Erk2 Does Not Perturb Surface
Expression of IL-7 Receptor or Pre-BCR but Results in Impaired
Cell Cycling
(A) Cell-cycle analysis of bone-marrow pro-B cells from p(I)p(C)-treated mice as
in Figure 1. BrdU-pulsed bone-marrow cells were stained with antibodies to
B220, CD43, and BrdU, then labeled with 7-AAD. Percentages of cells in G1,
S, and G2/M phases are shown in the gate of B220+CD43+ pro-B cells. Data
are representative of four individual mice.
(B) Percentage of S phase cells in the gate of B220+CD43+ pro-B cells as in (A).
The data are given as mean ± SD from four individual mice. *p = 0.004.
(C and D) FACS analysis of bone-marrow cells from control, Erk1-deficient, in-
ducible-Erk2-deficient, inducible-Erk double-deficient, Il7r/, or Rag1/
mice, showing histograms of expression of IL-7Ra (C) or pre-BCR (D) in
B220+CD43+pro-Bcells.Numbersshowthepercentageofcellswithin the region
marked by a horizontal bar. The pre-BCRwas detectedwith the SL156 antibody
recognizing a conformational epitope on the surrogate light-chain-Igm complex.Immunity 28, 499–508, April 2008 ª2008 Elsevier Inc. 501
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vival, as indicated by the observation that the number of dead
cells was increased in p(I)p(C)-treated inducible-Erk double-de-
ficient pro-B cells in the absence of IL-7 or low amount of IL-7
(Figure S2A). It has previously been demonstrated that the ability
to proliferate in low IL-7 concentrations requires not only pre-
BCR expression but also a signal downstream of the pre-BCR
and that downstream of the pre-BCR, the Erk pathway is essen-
tial in order to mediate this effect (Fleming and Paige, 2001).
Indeed, concordant with this notion, p(I)p(C)-treated inducible-
Erk double-deficient pro-B cells exhibited a response to IL-7
similar to that of Rag1/ or mMT pro-B cells (Figure S2B).
Defective In Vivo Signaling from Igb in the Absence
of Erk1 and Erk2
To examine directly whether Erk kinases transmit the pre-BCR
signals and thereby are essential for the pro-B to pre-B cell
Figure 4. Defective Pre-BCR Signaling in Inducible-Erk Double-
Deficient Pro-B Cells
(A) The rearranged mH gene was inserted into the retrovirus vector pMX-IRES-
GFP.Rag1/ pro-B cellswere infectedwith the indicated retrovirusand cultured
for24hr in theabsenceof IL-7prior toFACSanalysisofpre-BCR (SL156antibody)
or phosphorylated Erk. In the phosphorylated Erk analysis, MEK inhibitor U0126
(10 mM)was added to the culture for 12hr. Results are shown inGFP+gated cells.
(B) Proliferation was measured by [3H]-thymidine incorporation after 2 days of
culture of pro-B cells from the indicated mice. GFP+-sorted Rag1/ pro-B cells
infected with mH were analyzed as the pre-BCR+ Rag1/ control. A total of
0.16 ng/ml of IL-7 was added to the culture. The data show themean of triplicate
wells; error bars represent SD.
(C) FACSanalysisofbone-marrowcells fromRag1/miceorp(I)p(C)-treated ra-
diationchimeras reconstitutedwith inducible-Erkdouble-deficientbone-marrow
cells, 9 days after injection with PBS or Igb antibodies. In the upper panel,
Rag1/ mice (Ly9.1) were used as a control. In the lower panel, donor cells
(Ly9.1) reconstituted with irradiated Rag1/ mice (Ly9.1+) were analyzed.
CD19 versus CD2 plots are gated on Ly9.1 cells so that host cells were ex-
cluded. Percentages of CD2+ among CD19+ cells in mice analyzed are shown
(rightpanel). Thedataaregivenasmean±SDfromsix individualmice. *p=0.001.502 Immunity 28, 499–508, April 2008 ª2008 Elsevier Inc.developmental transition, we used a previously established
model in which injection of Igb antibody into Rag1/ mice was
able to induce differentiation of pro-B to pre-B cells (Nagata
et al., 1997). As expected, injection of Igb antibody into Rag1/
mice led to a large increase in pre-B cell number; however, no
such developmental restoration was seen in irradiated mice re-
constituted from p(I)p(C)-treated inducible-Erk double-deficient
bone-marrow cells (Figure 4C). This result reinforces the idea
that Erk1 and Erk2 are required to transduce an Igb signal, which
presumably mimicks the pre-BCR signal, thereby participating in
transition from pro-B to pre-B cells.
Constitutively Active MEK Rescues Expansion Defect
of Syk Zap70 Double-Deficient Pro-B Cells
Consistent with a previous report (Schweighoffer et al., 2003),
mb1-cre+ Sykfl/fl Zap70/ mice (Syk Zap70 double-deficient
mice, hereafter) (Figure S3) showed a complete block at the frac-
tion C stage in pro-B cells (Figure 5A). The similar developmental
arrest in p(I)p(C)-treated inducible-Erk double-deficient bone-
marrow B cells prompted us to test the hypothesis that the Erk
kinases function downstream of Syk and Zap70, thereby partici-
pating in pre-BCR-mediated expansion. Supporting this hypoth-
esis, Erk activation was dependent on expression of Syk and
Zap70 because increased phosphorylation of Erk was seen in
mMT control pro-B cells stimulated by anti-Igb crosslinking, but
not in Syk Zap70 double-deficient pro-B cells (Figure 5B). Cell-
surface expression of Igb between mMT and Syk Zap70 dou-
ble-deficient cells was similar (data not shown).
Next, we tested whether a constitutive active form of MEK
(MEK-CA), an Erk-activating kinase, can overcome defects due
to the loss of Syk and Zap70. Transduction of a retrovirus encod-
ing Syk into Syk Zap70 double-deficient pro-B cells induced a ro-
bust expansion in the presence of a low amount of IL-7. Under
these culture conditions, mMT pro-B cells never expanded un-
less transduced with mH, indicating that the expansion observed
is pre-BCR dependent. Importantly, expression of MEK-CA in
Syk Zap70 double-deficient pro-B cells corrected the expansion
defect due to the loss of Syk and Zap70 (Figure 5C). Hence, Erk
activation probably occurs downstream of Syk and Zap70 and is
crucial for pre-BCR-mediated cell expansion.
Pre-BCR-Induced Cell Expansion Is Controlled
by Erk-Dependent Gene Expression
In fibroblasts and PC12 cells, many growth factors elicit expres-
sion of a class of genes known as immediate-early genes (IEGs),
several of which encode transcription factors that regulate tran-
scription of genes directly involved in cell-cycle progression
such as the Ccnd1 gene (Roovers and Assoian, 2000). Thus,
we reasoned that Erk promoted pro-B cell expansion by regulat-
ing the mRNA expression of such IEGs or other transcription-
factor-encoding genes. We therefore sought transcription
factors that are induced after pre-BCR stimulation in an Erk-de-
pendent manner and that might influence pro-B cell expansion.
To obtain information of the transcription factors upregulated
by the Erk activation, we performed microarray analysis with
mMT pro-B cells. RNA was isolated from mMT pro-B cells unsti-
mulated or stimulated by anti-Igb for 0.75 hr or 6 hr in the pres-
ence or absence of MEK inhibitor and hybridized to arrays repre-
senting 39,000 markers. Of the genes assayed, 171 genes,
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upregulated in an Erk-dependentmanner either 0.75 hr or 6 hr af-
ter anti-Igb stimulation (Figure S4A). The expression of these
candidate transcription factors was further validated by quanti-
tative RT-PCR analysis, and 16 genes were confirmed as repro-
ducibly and substantially changed (Figures S4B and S4C). These
genes include IEGs such as Egr1, Egr2, Egr3,Myc, and Fos, the
expression of which showed a transient increase in an Erk-de-
pendent manner after anti-Igb stimulation.
To evaluate the role of these transcription factors in expanding
pro-B cells, we took a rescue approach in which overexpression
of these transcription factors can bypass the expansion defects
linked by loss of Erk1 and Erk2. Because in gene-targeting stud-
ies Xbp1 and Bach2 were previously reported as dispensable
genes for early B cell differentiation (Reimold et al., 2001; Muto
et al., 2004), we focused on testing the remaining 14 genes.
Figure 5. Constitutively Active MEK Can Bypass the Expansion
Defect of Syk Zap70 Double-Deficient Pro-B Cells
(A) FACS analysis of bone marrow from mb1-cre+ Syk+/+ Zap70+/+ (Control)
and mb1-cre+ Sykfl/fl Zap70/ (Syk Zap70 double-deficient) mice. Numbers
represent percentages of cells within the live cell fraction (B220 versus
CD43) or B220+CD43+ pro-B cell fraction (BP-1 versus HSA).
(B) Anti-Igb-induced Erk1 and Erk2 phosphorylation. CD19+ pro-B cells from
mMT or Syk Zap70 double-deficient mice were stimulated with Igb antibody
for the indicated times. Whole-cell lysate was separated by SDS-PAGE and
immunoblotted with phospho Erk (phos-Erk1, phos-Erk2) or Erk (Erk1, Erk2)
antibodies.
(C) CD19+ pro-B cells from Syk Zap70 double-deficient or mMT mice were in-
fected with the indicated retrovirus. The data show the kinetics of relative cell
number for each GFP+ transfectant during 4 days of culture in the presence of
0.01ng/ml of IL-7. The data are presented as the mean ± SD of triplicate.Among them, only four transcription factors, Myc, Ilf2, Mef2c,
and Mef2d, were able to restore the cell expansion of p(I)p(C)-
treated inducible-Erk double-deficient pro-B cells (Figure 6A),
suggesting that downstream of Erk, these four transcription fac-
tors may play a role in the cell expansion during the pro- to pre-B
cell transition. In further support of this possibility, Myc, Ilf2,
Mef2c, and Mef2d transcript expression was increased in large
cycling pre-B cells but subsequently downregulated in small
resting pre-B cells. Consistent with previous reports (Muljo and
Schlissel, 2003; van Zelm et al., 2005), expression of Kit was
downregulated in large cycling pre-B cells, whereas that of Irf4
was upregulated in small pre-B cells (Figure 6B).
Mutation in the Erk-Mediated Phosphorylation Sites
of Elk and CREB Inhibits Pre-BCR-Dependent
Cell Expansion
Having demonstrated the potential importance of Myc, Ilf2,
Mef2c, and Mef2d for pro-B cell expansion, we next wished to
determine how Erk regulates transcription of these genes. In
this regard, the existence of several Elk, Ets, and CREB binding
Figure 6. Identification of the Expansion-Promoting Genes
Activated by Erk
(A) B220+CD43+ pro-B cells from p(I)p(C) treated inducible-Erk double-defi-
cient mice were infected with the indicated retrovirus. The data show the
fold change of the cell number for each GFP+ transfectant during 4 days of
culture in the presence of 0.01 ng/ml of IL-7. *p = 0.0002, **p = 0.0015,
***p = 0.0001, and ****p = 0.0004, compared with mock transfectant. Data
are representative of at least three independent experiments and shown as
the mean ± SD of triplicate.
(B)Bone-marrowsubpopulationsofearlypro-B (B220+CD43+HSAlowIgMIgD),
late pro-B (B220+CD43+HSAhighIgMIgD), large pre-B (B220+CD43lowHSAhigh
IgMIgDFSChigh), and small pre-B (B220+CD43lowHSAhighIgMIgDFSClow)
were prepared by FACS sorting. Total RNA was analyzed by quantitative PCR,
with the expression ofMyc, Ilf2,Mef2c,Mef2d, Irf4, or Kit normalized to that of
Gapdh. Data are representative of at least three independent experiments and
shown as the mean ± SD of triplicate.Immunity 28, 499–508, April 2008 ª2008 Elsevier Inc. 503
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Action Mechanism of Erk Kinases in B CellFigure 7. Phosphorylation of Elk and CREB Is Required for Pre-BCR-Mediated Cell Expansion
(A) B220+ pro-B cells from Rag1/ mice were stimulated with Igb antibody for 3 min in the absence or presence of U0126 (20 mM). Whole-cell lysate was
separated by SDS-PAGE and immunoblotted with the indicated antibodies.
(B) B220+CD43+ pro-B cells from wild-type mice were infected with the indicated retrovirus. The data show the fold change of cell number for each GFP+ trans-
fectant during 4 days of culture in the presence of 0.01 ng/ml of IL-7. Data are representative of three independent experiments and presented as the mean ± SD
of triplicate wells. As the pre-BCR negative control, fold change of cell numbers in Rag1/ pro-B cells infected with mock is shown (left edge). *p = 0.006,
**p = 0.006, ***p = 0.01, and ****p = 0.005.
(C) B220+ pro-B cells from Rag1/ mice were infected with the indicated retrovirus. After 24 hr, GFP+ cells were sorted and stimulated with Igb antibody for
60 min. Total RNA was analyzed by quantitative PCR, with the expression of Myc, Ilf2, Mef2c, or Mef2d normalized to that of Gapdh. Data are representative
of three independent experiments and shown as the mean ± SD of triplicate.sites in these promoter regions allows us to hypothesize that pre-
BCR activates Erk, which in turn phosphorylates Elk, Ets, and/or
CREB, directly or indirectly (Figure S5). Then, phosphorylation of
these factors could activate their own transcriptional activity,
leading to upregulation of mRNA of Myc, Ilf2, Mef2c, and
Mef2d and thereby promoting B cell expansion.
Activated Erk is known to phosphorylate the C-terminal por-
tion of Elk-family transcription factors (two serine residues) and
N-terminal portion of Ets-family transcription factors (one threo-
nine residue); then, phosphorylated Elk and Ets are transcription-
ally activated (Buchwalter et al., 2004; Yang et al., 1996). CREB
belongs to the basic leucine zipper family of transcription
factors, and the transcriptional activity of CREB is reported to
require phosphorylation at Ser119 (Gonzalez and Montminy,
1989). Activation of Erk contributes to the phosphorylation of
CREB Ser119 via the Erk-dependent serine and threonine kinase
RSK (Roux and Blenis, 2004). Therefore, we examined whether
Elk1, Ets1, and CREB are phosphorylated after activation of
pro-B cells by anti-Igb crosslinking. By using antibodies that
specifically detected phosphorylated Elk1 at Ser384, phosphor-
ylated CREB at Ser119, and phosphorylated Ets1 at Thr38, we
found that after anti-Igb stimulation, such a phosphorylation in-
deed increased in an Erk-dependent manner (Figure 7A). To de-
termine whether phosphorylation of Elk1, Elk3, Elk4, CREB,
Ets1, and Ets2 participates in pro-B cell expansion, we gener-
ated dominant-negative forms of these factors in which the
Erk-mediated phosphorylation sites are mutated to Ala and in-
fected them into pro-B cells for evaluating pro-B cell expansion.
Whereas wild-type pro-B cells infected with mock retrovirus
showed efficient expansion 4 days after infection, mock infected
Rag1/ pro-B cells could not expand (Figure 7B). The difference504 Immunity 28, 499–508, April 2008 ª2008 Elsevier Inc.in the expansion of wild-type and Rag1/ cells under these cul-
ture conditions was due to the lack of expression of pre-BCR,
and indeed forced expression of surface pre-BCR on Rag1/
cells resulted in an efficient expansion under the same condi-
tions (data not shown). Forced expression of wild-type forms
of Elk-1, Elk-3, Elk-4, CREB, Ets1, and Ets2 did not affect B
cell expansion as much. In contrast, expression of dominant-
negative mutants of Elk1, Elk3, Elk4, or CREB strongly inhibited
cell expansion, suggesting the importance of the Erk-mediated
phosphorylation sites of these factors in pro-B cell expansion
(Figure 7B). On the other hand, transduction of pro-B cells with
a dominant-negative form of Ets1 or Ets2 marginally affected
the expansion.
To further test whether phosphorylation of Elk1 and CREB af-
fects expression of Myc, Ilf2, Mef2c, and Mef2d, we introduced
the above dominant-negative mutant of Elk1 or CREB into
Rag1/ pro-B cells, and the expression status of Myc, Ilf2,
Mef2c, andMef2d was determined after anti-Igb stimulation. As
shown in Figure 7C, forced expression of Elk1 S384A+S390A
completely inhibited the induction of Myc and Ilf2 transcripts. In
contrast, forcedexpression ofCREBS119Aseverely suppressed
the induction ofMef2c andMef2d transcripts. Collectively, these
data suggest that Elk1 and CREB, after being phosphorylated
directly or indirectly by Erk, contribute to upregulation of Myc,
Ilf2,Mef2c, andMef2d, thereby promoting pro-B cell expansion.
DISCUSSION
Here, we have addressed whether Erk signaling plays a substan-
tial role in the pre-BCR-regulated checkpoint in B cell develop-
ment and how these kinases exert their function, if any. Our
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an apparently ligand-independent manner, which in turn is criti-
cal for pre-BCR-mediated cell expansion. In addition, our data
suggest that the activated Erk kinases mediate phosphorylation
of transcription factors such as Elk1 and CREB, thereby regulat-
ing their potential target genes and promoting pre-BCR-medi-
ated expansion (Figure S6). In contrast to direct phosphorylation
of the Elk family by Erk, CREB is most probably phosphorylated
by Erk-activated RSK (Roux and Blenis, 2004).
Previous reports suggest the existence of two separate path-
ways in pre-BCR signaling, the SFK dependent and the Syk and
Zap70dependent pathways that are crucial in pre-Bcell develop-
ment throughNF-kB-dependent and -independentmechanisms,
respectively (Schweighoffer et al., 2003; Saijo et al., 2003). Here,
two linesof evidence allowus toconclude that theErk-dependent
mechanism is operating downstream of Syk and Zap70, and this
in turn contributes to pre-B cell development. First, Igb-mediated
Erk activation is completely inhibited in Syk Zap70 double-defi-
cient pro-B cells, and second, pre-BCR-mediated expansion is
restored by introduction of constitutive active MEK in Syk
Zap70 double-deficient cells. The latter evidence further sug-
gests that the Erk pathway is not only necessary but also appears
to be sufficient for mediating the proliferative function of the pre-
BCR. Thequestion thenarisesof themechanismconnectingSyk/
Zap70andErk1/2.Lat/Blnk/andPlcg1+/Plcg2/miceex-
hibit a similar early B cell developmental arrest (as assessed by
CD43 expression) as p(I)p(C)-treated inducible-Erk double-defi-
cient mice (Su and Jumaa, 2003; Wen et al., 2004). Moreover, in
mature B cells, BCR-mediated Ras and subsequent Erk activa-
tion are severely affected, although not completely, in PLCg2-de-
ficient B cells (Bell et al., 2004). Thus, assuming that a similar sig-
naling cascade takes place in the case of pre-BCR, these data
suggest that SLP-76 and BLNK, after being phosphorylated by
Syk and Zap70, participate in the pre-BCR-mediated PLCg acti-
vation, therebycontributing to theRas-Erkpathway.According to
this model, RasGRPs could connect the PLCg activity to the Ras
and Erk activation because these molecules have a C1 domain
that binds to DAG, a product of PLCg (Oh-hora et al., 2003). Be-
cause a recent report suggests that Sos, another GEF for Ras,
can be activated by ITAM-containing receptors, Sos could also
contribute to the Ras-Erk pathway as well (Roose et al., 2007).
In contrast to loss of in vitro expansion of Erk double-deficient
pro- and pre-B cells,Btk/ orBlnk/ pre-B cells exhibited a 10-
to 15-fold increase in vitro expansion of pre-B cells (Middendorp
et al., 2002; Flemming et al., 2003). This hyperexpansion is prob-
ably due to dysregulated pre-BCR signaling because this anom-
aly was abrogated in l5 BLNK double-deficient B cells (Flem-
ming et al., 2003). These data imply two things: First, given the
evidence that PLCg activation is decreased, but still occurs, in
Btk/ or Blnk/ pre-B cells, this residual PLCg activation might
be enough to induce a certain degree of Ras and Erk activation
required for pre-B cell expansion. Second, Btk and BLNK might
possess antiproliferative functions for instance through downre-
gulation of surrogate light chains and/or IL-7R components, in
addition to activating PLCg2. According to this scenario, a defect
in such antiproliferative functions might be dominantly mani-
fested in these knockout mice.
Our results demonstrate that the Elk family andCREB and their
target genes constitute a link between Erk signaling and the tran-scriptional programs required to execute pre-B cell expansion.
Indeed, phosphorylation of both Elk1 and CREB was apparently
enhanced in large cycling pre-B cell stage (data not shown). By
using dominant-negative interfering mutants of Elk1 and CREB
in which Erk-mediated phosphorylation sites are changed to
Ala, we argue that Elk1 activates expression ofMyc and Ilf2, pref-
erentially, whereas CREB regulatesMef2c andMef2d in the pre-
BCR signaling context. Because the dominant-negative ap-
proach may cause undesired side effects, these results should
be carefully interpreted. However, the following three lines of
the evidence seem to substantiate our idea: First, like effects
of such dominant-negative forms of Elk1 and CREB, expression
of Myc, Ilf2, Mef2c, and Mef2d genes was totally dependent on
Erk activation. Second, Myc and Ilf2 promoter regions contain
multiple Elk and Ets binding sites, whereas Mef2c and Mef2d
have multiple CREB binding sites. Finally, our chromatin-immu-
noprecipitation assays indicate that Elk1 binds to the Myc and
Ilf2 promoter, constitutively and inducibly, respectively, after
anti-Igb stimulation, whereas CREB binds to the Mef2c and
Mef2d promoter constitutively (Figure S7). The inducible binding
of Elk1 to the Ilf2 promoter region is somewhat unexpected.
Because this binding was also blocked by treatment of a MEK
inhibitor (Figure S7), one of the straightforward explanations for
this result is that Erk-mediated phosphorylation on Elk1 might
regulate its accessibility to the Ilf2 promoter region, in addition
to promoting the transcriptional activity of Elk1.
The importance of Erk-mediated phosphorylation on CREB in
a pre-BCR checking point is supported by a previous report.
Transgenic mice overexpressing a dominant-negative CREB
(Ser119-to-Ala mutant) in a B cell-specific manner showed a de-
velopmental block in the transition of pro- to pre-B cells (Chen
et al., 2006). In contrast to CREB, single deficiency of the Elk
members Elk1, Elk3, and Elk4 resulted in apparently normal B
cell development, although this has not been analyzed in detail
(Cesari et al., 2004; Costello et al., 2004). However, in light of
the structural similarities among these members, it is still possi-
ble that a certain degree of functional compensation between
them may operate in B cells, thereby tempering the phenotype.
Indeed, in our assay systems, dominant-negative forms of Elk3
and Elk4 were similar to Elk1 in terms of their inhibitory potentials
(data not shown).
Accumulating evidence gathered from different experimental
systems indicate that c-Myc regulates the mitogenic induction
of cell growth (Pelengaris et al., 2002). Here, we extend this ev-
idence to include pre-BCR-activated B cells. In accord with
our findings, a recent report has demonstrated that overexpres-
sion of c-Myc stimulated expansion of ‘‘pre-B’’-like cells from
pro-B cells in the absence of pre-BCR formation (in Rag2/
mice) (Habib et al., 2007). Furthermore, this report has shown
that B cell-specific deletion of c-Myc and N-Myc inhibited B
cell development at the pro- to pre-B cell transition. In mature
primary B cells, BCR and LPS-mediated upregulation of Myc
transcript was severely affected in the presence of LY294002
(PI3K inhibitor) or in the absence of NF-kB1 and c-Rel, whereas
treatment of PD98059 (MEK inhibitor) did not affect the upregu-
lation (Grumont et al., 2002). Although we did not determine
whether the PI3K pathway is also involved in pre-BCR-mediated
Myc transcription, it is likely that pre-BCR utilizes the Erk path-
way, in addition to the PI3K-dependent NF-kB pathway, toImmunity 28, 499–508, April 2008 ª2008 Elsevier Inc. 505
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a MEK inhibitor did not completely abrogate Igb-mediated
upregulation of Myc in pro-B cells (Figures S4B and S4C).
AlthoughMEF2was initially identified as a regulator of muscle-
gene expression, its importance in T cell biology has also been
demonstrated. Drosophila possesses a single Mef2 gene,
whereas vertebrates have four—Mef2a, Mef2b, Mef2c, and
Mef2d. Nur77 is a crucial mediator of TCR-induced apoptosis,
and expression of Nur77 is mediated through two MEF2 sites
in the Nur77 promoter. The following observations together sug-
gest the involvement of MEF2 proteins in thymocyte negative
selection. In unstimulated T cells, MEF2B is associatedwith tran-
scriptional corepressors, such as HDAC7 and Cabin1, that in-
hibit Nur77 expression (Youn and Liu, 2000). After TCR activa-
tion, HDAC7 becomes dissociated from MEF2D through
nucleocytoplasmic shuttling. Phosphorylation of HDAC7 by
PKD1, a PI3K-activated kinase, recruits 14-3-3 and translocates
HDAC7 to the cytoplasm, allowing the activation of MEF2 pro-
teins (Dequiedt et al., 2005). If a similar regulation occurs in the
case of BCR and pre-BCR signaling, our findings implicate the
existence of another layer of regulation of MEF2 family genes,
namely their transcriptional regulation by the Erk pathway. In
Drosophila, MEF2 regulates a striking number of genes that en-
code components of various signaling pathways including the fi-
broblast growth factor and epidermal growth factor (Sandmann
et al., 2006). This allows us to suggest that the pre-BCR signaling
components could be MEF2C and MEF2D targets, thereby en-
hancing pre-B cell expansion. In contrast with c-Myc, MEF2C,
and MEF2D, very little is known on the role of ILF2 in lymphocyte
function, except that ILF2 regulates transcription of IL-2 in
cultured T cells (Zhao et al., 2005).
Our results suggest that the poor expansion of pre-B cells due
to insufficient upregulation ofMyc, Ilf2,Mef2c, andMef2dmight
be one reason for the observed developmental defect in the ab-
sence of both Erk1 and Erk2. This proposal, however, does not
preclude the following possibilities: First, gene products downre-
gulated by pre-BCR in an Erk-dependent manner might also
contribute to pre-B cell expansion. In fibroblasts, Tob1 and
Ddit3 are candidate genes. Expression of antiproliferative genes
Tob1 and Ddit3 are downregulated after FGF stimulation (Yama-
moto et al., 2006). Second, Ras-Erk signaling pathway is thought
to be important for cell survival by transcription-dependent
and -independent mechanisms (Bonni et al., 1999). In fact, Erk
double-deficient pro-B cells were more susceptible to cell death
than wild-type cells (Figure S2A). We also found that transcrip-
tion of Bcl2 prosurvival gene was activated by anti-Igb stimula-
tion of mMT pro-B cells in an Erk-dependent manner (data not
shown). Given the previous evidence that phosphorylation at
S119 of CREB induces Bcl2 expression during B cell activation
and rescue from apoptosis (Zhang et al., 2002), it is reasonable
to anticipate that this Erk-mediated survival defect in the Erk
double-deficient mice could, at least partly, contribute to the de-
fective expansion and subsequent developmental block. Third,
apart from transcriptional regulation, Erk-mediated phosphory-
lation might directly regulate the components of the cell cycle
and/or survival system, leading to pre-B cell expansion. For in-
stance, the observed survival defect in the absence of Erk1
and Erk2 might be explained by insufficient phosphorylation of
the proapoptotic product Bim, a protein known to undergo ubiq-506 Immunity 28, 499–508, April 2008 ª2008 Elsevier Inc.uitination and subsequent proteasomal degradation upon Erk-
mediated phosphorylation (Craxton et al., 2005). In this regard,
in addition to the transcriptional regulation of Myc by Erk dis-
cussed above, the Erk pathway could regulate c-Myc protein
stability by its phosphorylation (Sears et al., 2000).
The pre-BCR signal is thought to induce several rounds of pro-
liferation and to direct epigenetic changes resulting in the allelic
exclusion of the heavy-chain locus and in the activation of the
light-chain loci for V(D)J recombination. Developmental block-
ade from pro-B to pre-B cells in the Erk double-deficient mice
has enabled us to propose the connecting mechanism between
Erk and pre-B cell expansion. However, whether the Erk kinases
participate in allelic exclusion and light-chain gene rearrange-
ment remains to be determined.
EXPERIMENTAL PROCEDURES
Mice
Mapk1fl/fl mice and Mapk3/ mice have been described previously (Hatano
et al., 2003; Page`s et al., 1999). These mice were crossed to Mx-cre mice
for generation of Mx-cre+ Mapk3+/ Mapk1fl/fl or Mx-cre+ Mapk3/ Mapk1fl/fl
mice (Kuhn et al., 1995). To achieve the deletion of Mapk1 flox allele, we in-
duced Cre expression by three i.p. injections of p(I)p(C) (400 mg in PBS; Sigma)
every third day. mMT and Il7r/ mice have been described previously (Kita-
mura et al., 1991; Maki et al., 1996). The generation of Sykfl/fl mice is described
in detail in the Supplemental Data. We crossed Sykfl/fl mice to mb1-cre mice
and Zap70/ mice to generate mb1-cre+ Sykfl/fl Zap70/ mice (Hobeika
et al., 2006; Negishi et al., 1995). The mb1-cre mice were kindly provided as
a gift from Dr. Michael Reth. Mice were bred and maintained under specific
pathogen-free conditions and analyzed at the age of 7–16 weeks. Animal
care and experiments were conducted according to the guidelines established
by the RIKEN animal committee.
Radiation Chimeras
For Figures 2 and 4C, recipient mice were irradiated with a dose of 600 rad; this
was followed by i.v. injection of 5 3 106 donor bone-marrow cells. Mice were
given 0.16% neomycin-sulfate (Sigma) in their drinking water for 2 weeks after
transfer. Two weeks after transfer, mice were given three i.p. injections of
p(I)p(C) and analyzed 2 weeks after the first p(I)p(C) injection. Radiation chi-
meras were generated with BALB/c background Rag1/ recipient mice
(Ly9.1+) and donor bone-marrow cells on the C57BL/6 (Ly9.1) background.
Anti-Igb in vivo stimulation (Figure 4C) was performed as previously described
(Nagata et al., 1997).
Flow Cytometry and Cell Sorting
Single cells were stained with various fluorochrome-conjugated antibodies
purchased from BD PharMingen or eBioscience (see Supplemental Experi-
mental Procedures). Dead cells were excluded from the analysis with propi-
dium iodide. For cell-cycle analysis, bone-marrow cells pulsed with 10 mM of
bromodeoxyuridine (BrdU) for 2 hr of culture were stained with antibodies to
B220, CD43, and BrdU, then labeled with 7-amino-actinocycin D (7-AAD).
All analyses were made with a FACSCalibur (BD Biosciences). Specific cell
populations were either sorted on a FACSVantage (BDBiosciences) or isolated
by magnetic cell sorting with B220 or CD19 microbeads (Miltenyi Biotech).
Retroviral Transduction
Retroviral vector expressingmembrane mHwas described previously (Kawano
et al., 2006). cDNA fragments were obtained from mouse splenic B cells by
PCR amplification with the primers listed in Table S1. These cDNAs were
verified by sequencing analysis and inserted into pMX-IRES-GFP vector as
described in the Supplemental Experimental Procedures. Retroviral infection
was described previously (Kawano et al., 2006).
In Vitro Pro-B Cell Culture
Cells were grown in Iscove’s Modified Dulbecco’s Medium (GIBCO) supple-
mented with 10% FCS, 50 mM 2-ME, penicillin, streptomycin, and the
Immunity
Action Mechanism of Erk Kinases in B Cellindicated factors. For [3H]-thymidine incorporation assay, cells were plated in
triplicate at 105 cells/well in 96-well plates and measured on day 2 by addition
of 0.5 mCi [3H]-thymidine 12 hr prior to the harvest. [3H] incorporation wasmea-
sured with a beta counter system (PerkinElmer). Retrovirally transduced pro-B
cells were counted at the indicated day as previously described (Kawano et al.,
2006).
Gene-Expression Analysis
For quantitative RT-PCR analysis, randomly primed cDNA strands were gen-
erated with reverse transcriptase II (Invitrogen). With the gene-specific primers
listed in Table S2, mRNA expression was quantified by iCycler (Bio-Rad Lab-
oratories).
Immunoblotting
CD19+ pro-B cells from mMT or mb1-cre+ Sykfl/fl Zap70/ mice and B220+
pro-B cells from Rag1/ mice were pretreated with 30 mg/ml of biotin-conju-
gated IgbmAb HM79 for 20 min on ice in the presence or absence of 20 mM of
U0126. After addition of 30 mg/ml of streptavidin, the cells were incubated at
37C for the indicated time. Cell lysates were separated on 5%–20% SDS-
PAGE and transferred to a polyvinylidene difluoride membrane (Millipore).
The membrane was immunoblotted with specific antibodies (see Supplemen-
tal Experimental Procedures).
Statistical Analysis
Statistical significance was calculated with the two-tailed Student’s t test. All
p values of less than 0.05 were considered significant.
ACCESSION NUMBERS
The microarray data have been deposited in CIBEX under accession number
CBX58.
SUPPLEMENTAL DATA
Additional Experimental Procedures, seven figures, and two tables are avail-
able at http://www.immunity.com/cgi/content/full/28/4/499/DC1/.
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